Screening as a method of early effective diagnostics of gastric cancer
Keywordsgastric cancer, screening, prevalence, mortality rate
One of the most common forms of malignant neoplasms in the world for more than a decade is gastric cancer. It ranks 2nd in the structure of overall cancer and tends to grow steadily. According to the latest data, the WHO registers 750-850 thousand new cases of gastric cancer every year and more than 600 thousand people die from this disease . Almost the only preventive method today, aimed at early detection of tumors is cancer screening. Its use helps to reduce mortality rate from certain types of malignant neoplasms including gastric cancer. Reasonability to perform screening of the population for malignant neoplasms in Ukraine today remains a matter of debate due to lack of awareness of the population and doctors, lack of clear understanding of the concept and process of screening, complexity and relatively high cost of screening methods, insufficient convincing evidence of its need for certain nosology of malignant tumors . But at the same time, there is an urgent need inUkraine to introduce a gastric cancer screening program to determine its type, as well as to substantiate its reasonability.
BULLETIN OF NATIONAL CANCER REGISTRY OF UKRAINE (ENGLISH) vol.21
Hosokawa O., Hattori M., Takeda T., Watanabe K., Fujita M. Accuracy of endoscopy in detecting gastric cancer // J.Gastroenterol. Mass. Surv. – 2004. – Vol.42. – P.33-39 (in Japanese).
Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistics, 2007 // CA Cancer J. Clin. – 2007. – Vol.57. – P.43-66.
Kunisaki C., Ishino J., Nakajima S. et al. Outcomes of mass screening for gastric carcinoma // Ann. Surg. Oncol. – 2006.– Vol.13. – P.221-228.
Martin S Karpeh, David P Kelsen, Joel E Tepper. Cancer of the Stomach Cancer: Principles and Practice of Oncology, 7th Edition Published by Lippincott Williams & Wilkins, Copyright. – 2005.
Miki K. Gastric cancer screening using the serum pepsinogen test method // Gastric Cancer. – 2006. – Vol.9. – P.245-253.
Mukoubayashi C., Yanaoka K., Ohata H. et al. Serum pepsinogen and gastric cancer screening // Intern. Med. – 2007. –Vol.46. – P.261-266.
Tajima K., Kuroishi T., Oshima A., eds. Cancer mortality and morbidity statistics: Japan and the world 2004. Tokyo: Japan Scientific Societies Press, 2004. Japanese cancer association Gann monograph on cancer research no.
Tashiro A., Sano M., Kinameri K., Fujita K., Takeuchi Y. Comparing mass screening techniques for gastric cancer in Japan// World J. Gastroenterol. – 2006. – Vol.12(30) . – P.4873-4874.
Wai K. Leung, Mingshiang Wu, Yasuo Kakugawa. Screening for gastric cancer in Asia: current evidence and practice //Lancet. Oncol. – 2008. – Vol.9. – P.279-287.
Watabe H., Mitsushima T., Yamaji Y., Okamoto M., Wada R., Kokubo T. et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study // Gut.– 2005. – Vol.54. – P.764-768.
Young Min Kwon, Hyung Taek. Lim Factors associated with use of gastric cancer screening services in KoreaWorld //J. Gastroenterol. – 2009, August 7. – Vol.15(29) . – P.3653-3659.
How to Cite
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Number of views and downloads: 187
Number of citations: 0